Main Line cell therapy startup adds Adaptimmune's CTO to its team
December 13, 2018 at 11:57 AM EST
Cabaletta Bio makes its first big hire since raising $38 million last month.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.